Literature DB >> 8297478

Distribution of insulin-like growth factor-I receptor mRNA in rat brain. Regulation in the hypothalamo-neurohypophysial system.

F Aguado1, J Rodrigo, L Cacicedo, B Mellström.   

Abstract

The distribution and regulation of mRNA for the IGF-I receptor (IGF-I-R) in the adult rat brain were studied by in-situ hybridization with a 35S-labelled cRNA probe. The pituitary gland showed a strong hybridization signal in the pars tuberalis (the surface of the median eminence), pars distalis and pars intermedia. Within the brain, a strong hybridization signal was found in the circumventricular organs, olfactory bulb, hippocampus, cerebellum and hypothalamus. IGF-I-R mRNA was consistently found in cell bodies of the hypothalamo-neurohypophysial system. Six days of intermittent salt-loading resulted in an increase in IGF-I-R gene expression in the supraoptic nucleus. The increase in IGF-I-R mRNA was accompanied by a high expression of c-Fos immunoreactivity in the same cells. The presence and regulation of IGF-I-R mRNA in the hypothalamus suggest that IGF-I may affect the local plasticity or modulation of activated magnocellular neurones by an autocrine or paracrine action through specific receptors in the hypothalamo-neurohypophysial system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8297478     DOI: 10.1677/jme.0.0110231

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  13 in total

1.  Central peptidergic neurons are hyperactive during collateral sprouting and inhibition of activity suppresses sprouting.

Authors:  J A Watt; C W Moffet; X Zhou; S Short; J P Herman; C M Paden
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  Activity-dependent IGF-1 exocytosis is controlled by the Ca(2+)-sensor synaptotagmin-10.

Authors:  Peng Cao; Anton Maximov; Thomas C Südhof
Journal:  Cell       Date:  2011-04-15       Impact factor: 41.582

3.  Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

Authors:  Brian A Hoshaw; Tiffany I Hill; James J Crowley; Jessica E Malberg; Xavier Khawaja; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Journal:  Eur J Pharmacol       Date:  2008-07-17       Impact factor: 4.432

4.  A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.

Authors:  N Yokomori; R Kobayashi; R Moore; T Sueyoshi; M Negishi
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

Review 5.  Serum growth factors and neuroprotective surveillance: focus on IGF-1.

Authors:  I Torres-Aleman
Journal:  Mol Neurobiol       Date:  2000-06       Impact factor: 5.590

6.  Sexually dimorphic DNA demethylation in the promoter of the Slp (sex-limited protein) gene in mouse liver.

Authors:  N Yokomori; R Moore; M Negishi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Growth hormone deficiency and cerebral palsy.

Authors:  Jesús Devesa; Nerea Casteleiro; Cristina Rodicio; Natalia López; Pedro Reimunde
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

8.  Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy.

Authors:  Pedro Reimunde; Cristina Rodicio; Natalia López; Alba Alonso; Pablo Devesa; Jesús Devesa
Journal:  Ther Clin Risk Manag       Date:  2010-11-30       Impact factor: 2.423

9.  Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampus.

Authors:  Jihui Zhang; Billie M Moats-Staats; Ping Ye; A Joseph D'Ercole
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

Review 10.  Actions and interactions of alcohol and insulin-like growth factor-1 on female pubertal development.

Authors:  W Les Dees; Vinod Srivastava; Jill K Hiney
Journal:  Alcohol Clin Exp Res       Date:  2009-08-31       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.